Chevron
Go back
SAGE Therapeutics logo

SAGE Therapeutics

Since December 31, 2009
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Icon, Cambridge, United States
Cambridge, United States
Icon, 501 — 1000 employees
501 — 1000 employees
Icon, Raised $2.7B
Raised $2.7B
Biotechnology
Medical
Therapeutics
Post-IPO Equity
November 27, 2020
$650M
See all investors and rounds